- Home
- CMBM vs COSM Comparison
CMBM vs COSM Comparison
Compare CMBM & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- COSM
- Stock Information
- Founded
- CMBM 2011
- COSM 2009
- Country
- CMBM United States
- COSM Greece
- Employees
- CMBM N/A
- COSM N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- COSM Other Pharmaceuticals
- Sector
- CMBM Technology
- COSM Health Care
- Exchange
- CMBM Nasdaq
- COSM Nasdaq
- Market Cap
- CMBM 12.1M
- COSM 8.2M
- IPO Year
- CMBM 2019
- COSM 2013
- Fundamental
- Price
- CMBM $0.45
- COSM $0.43
- Analyst Decision
- CMBM Strong Buy
- COSM
- Analyst Count
- CMBM 2
- COSM 0
- Target Price
- CMBM $5.50
- COSM N/A
- AVG Volume (30 Days)
- CMBM 140.5K
- COSM 749.7K
- Earning Date
- CMBM 05-16-2025
- COSM 04-16-2025
- Dividend Yield
- CMBM N/A
- COSM N/A
- EPS Growth
- CMBM N/A
- COSM N/A
- EPS
- CMBM N/A
- COSM N/A
- Revenue
- CMBM $172,215,000.00
- COSM $54,426,402.00
- Revenue This Year
- CMBM N/A
- COSM $28.14
- Revenue Next Year
- CMBM $17.13
- COSM N/A
- P/E Ratio
- CMBM N/A
- COSM N/A
- Revenue Growth
- CMBM N/A
- COSM 1.97
- 52 Week Low
- CMBM $0.23
- COSM $0.28
- 52 Week High
- CMBM $4.16
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- CMBM 47.95
- COSM 52.13
- Support Level
- CMBM $0.42
- COSM $0.40
- Resistance Level
- CMBM $0.41
- COSM $0.55
- Average True Range (ATR)
- CMBM 0.03
- COSM 0.06
- MACD
- CMBM 0.02
- COSM 0.01
- Stochastic Oscillator
- CMBM 72.70
- COSM 56.06
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.